A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)
Clinical trial NCT02627963 · COMPLETED
Trial details
- NCT number
- NCT02627963
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-24
- Primary completion
- 2018-10-04
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.